tiprankstipranks
Banka BioLoo Ltd. (IN:BANKA)
:BANKA
India Market
Want to see IN:BANKA full AI Analyst Report?

Banka BioLoo Ltd. (BANKA) AI Stock Analysis

0 Followers

Top Page

IN:BANKA

Banka BioLoo Ltd.

(BANKA)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 5.2)
Rating:57Neutral
Price Target:
₹90.00
▲(34.77% Upside)
Action:Reiterated
Date:05/28/26
The score is held back primarily by weak and negative recent operating/free cash flow and higher leverage alongside volatile profitability. Offsetting this, technicals are strong with price above key moving averages and positive MACD, and valuation looks favorable with a low P/E.
Positive Factors
Steady multi‑year revenue growth
Sustained top‑line expansion over several years indicates persistent demand for the company’s solutions and progress scaling operations. Multi‑year revenue momentum supports long‑term margin recovery and provides a base to absorb fixed costs and pursue incremental market penetration.
Negative Factors
Weak operating and free cash flow
Persistent negative operating and free cash flow signals the business currently consumes cash to fund operations and capex. This reduces self‑funding ability for growth, increases refinancing risk, and forces reliance on external capital or debt, constraining strategic flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady multi‑year revenue growth
Sustained top‑line expansion over several years indicates persistent demand for the company’s solutions and progress scaling operations. Multi‑year revenue momentum supports long‑term margin recovery and provides a base to absorb fixed costs and pursue incremental market penetration.
Read all positive factors

Banka BioLoo Ltd. (BANKA) vs. iShares MSCI India ETF (INDA)

Banka BioLoo Ltd. Business Overview & Revenue Model

Company Description
Banka BioLoo Limited is an Indian enterprise offering a comprehensive suite of products and services for sanitation and waste management. A key aspect of its operations involves the design, provision, and deployment of bio-toilets. Beyond installa...
How the Company Makes Money
null...

Banka BioLoo Ltd. Financial Statement Overview

Summary
Despite steady multi-year revenue growth and a return to small profit in FY2026, results remain constrained by volatile profitability, rising leverage (debt-to-equity above 1.0x in FY2025–FY2026), and persistently weak cash generation with negative operating and free cash flow in recent periods.
Income Statement
46
Neutral
Balance Sheet
52
Neutral
Cash Flow
28
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue530.30M570.92M541.74M499.96M423.50M387.51M
Gross Profit262.07M58.70M9.87M337.57M368.11M320.30M
EBITDA14.70M51.97M-28.60M41.85M66.06M58.91M
Net Income-41.50M3.93M-89.09M-6.53M25.39M31.08M
Balance Sheet
Total Assets801.17M1.01B821.55M774.23M652.07M640.54M
Cash, Cash Equivalents and Short-Term Investments19.66M110.08M40.70M16.88M13.41M8.29M
Total Debt323.93M408.03M347.28M259.13M167.15M184.96M
Total Liabilities494.26M581.35M505.70M376.61M251.09M265.52M
Stockholders Equity306.25M395.55M315.13M397.20M400.99M375.02M
Cash Flow
Free Cash Flow11.47M-82.89M-69.53M-72.06M9.40M-36.00M
Operating Cash Flow42.83M-22.92M-24.71M27.63M73.53M-4.40M
Investing Cash Flow-5.01M-24.17M-63.44M-100.69M-57.18M-27.17M
Financing Cash Flow-39.54M146.75M87.50M67.76M-33.29M9.55M

Banka BioLoo Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price66.78
Price Trends
50DMA
81.66
Positive
100DMA
68.76
Positive
200DMA
73.95
Positive
Market Momentum
MACD
2.47
Positive
RSI
59.22
Neutral
STOCH
34.65
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BANKA, the sentiment is Positive. The current price of 66.78 is below the 20-day moving average (MA) of 88.84, below the 50-day MA of 81.66, and below the 200-day MA of 73.95, indicating a bullish trend. The MACD of 2.47 indicates Positive momentum. The RSI at 59.22 is Neutral, neither overbought nor oversold. The STOCH value of 34.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BANKA.

Banka BioLoo Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
₹5.31B24.140.87%10.84%1.07%
58
Neutral
₹3.25B25.7414.46%75.86%
57
Neutral
₹979.45M265.835.39%
55
Neutral
$13.29B17.4210.03%0.93%7.13%-12.93%
40
Underperform
₹4.08B310.72-41.53%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:BANKA
Banka BioLoo Ltd.
89.00
19.81
28.63%
IN:IL&FSENGG
IL&FS Engineering & Construction Co. Ltd.
32.07
-3.21
-9.10%
IN:INTLTRAVHS
International Travel House Limited
309.45
-191.26
-38.20%
IN:MAHEPC
Mahindra EPC Irrigation Limited
116.60
-19.90
-14.58%
IN:SAYAJIHOTL
Sayaji Hotels Limited
292.10
11.10
3.95%
IN:SPECIALITY
Speciality Restaurants Ltd.
118.45
-6.98
-5.56%

Banka BioLoo Ltd. Corporate Events

Banka BioLoo Clears FY26 Results and Tightens Governance Framework
May 26, 2026
Banka BioLoo Ltd. has approved its audited standalone and consolidated financial results for the quarter and financial year ended 31 March 2026, along with the associated auditors’ reports, and will publish these figures on its website and i...
Banka BioLoo’s Company Secretary and Compliance Officer Resigns Effective April 2026
Apr 17, 2026
Banka BioLoo Ltd. has announced that Mrs. Nitika Lakhotia has resigned from her role as Company Secretary and Compliance Officer, with her cessation effective after the close of business on 30 April 2026. The company stated that her resignation, w...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 28, 2026